Brca1 mutations in the coiled-coil domain impede Rad51 loading on DNA and mouse development
We recently developed a Brca1 coiled-coil mutant mouse model (Brca1CC). Brca1CC/CC results in embryonic lethality, with a fraction of mice reaching birth but with defects that parallel Fanconi anemia. Brca1CC/CC cells lacked Rad51 foci and were PARP inhibitor sensitive. Strikingly, inter-crossing wi...
Main Authors: | J. J. Krais, N. Johnson |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2020-09-01
|
Series: | Molecular & Cellular Oncology |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/23723556.2020.1786345 |
Similar Items
-
A RAD51 assay feasible in routine tumor samples calls PARP inhibitor response beyond BRCA mutation
by: Marta Castroviejo‐Bermejo, et al.
Published: (2018-10-01) -
BRCA1-methylated triple negative breast cancers previously exposed to neoadjuvant chemotherapy form RAD51 foci and respond poorly to olaparib
by: Carolina Velazquez, et al.
Published: (2023-03-01) -
Conserved architecture of RAD51 recombinase in ruminants revealed through molecular cloning and characterization
by: SONIKA AHLAWAT, et al.
Published: (2016-12-01) -
BRCA2 BRC missense variants disrupt RAD51-dependent DNA repair
by: Judit Jimenez-Sainz, et al.
Published: (2022-09-01) -
Rad52-Rad51 association is essential to protect Rad51 filaments against Srs2, but facultative for filament formation
by: Emilie Ma, et al.
Published: (2018-07-01)